BlueWind Medical Appoints Lori Chmura as Chair of the Board of Directors

PARK CITY, Utah , Sept. 16, 2024 /PRNewswire/ -- BlueWind Medical, a pioneer in implantable Tibial NeuroModulation (iTNM) and the developer of Revi ® , a patient-centric solution for urge urinary incontinence (UUI), announced today that Lori Chmura has been elected to serve as the Chair of its Board of Directors effective September 6th . Ms.

Chmura is a distinguished executive with over 30 years' experience in the MedTech industry. She has successfully led multiple privately held, venture backed companies and held key sales and marketing leadership roles at some of the world's largest global medical device companies. Leveraging her proven track record of transforming businesses and driving growth, Ms.

Chmura's appointment as the Chair for BlueWind Medical's Board will be invaluable as BlueWind Medical continues to innovate and expand commercially. Ms. Chmura is currently Chief Executive Officer and Board Director at Nyra Medical, an innovative medical device company developing a next generation transcatheter mitral valve repair technology.

Prior to joining Nyra Medical, she served as Chief Executive Officer, and Board Director at Soundbite Medical Solutions and Dune Medical Devices, where she led the restructuring of both businesses resulting in a cross-border licensing deal at one company, and an acquisition of the other. In addition, Ms. Chmura brings leadership experience in several large multi-national medical device companies, including positions with Medtronic, Covidie.